NO20091081L - Oganiske forbindelser - Google Patents

Oganiske forbindelser

Info

Publication number
NO20091081L
NO20091081L NO20091081A NO20091081A NO20091081L NO 20091081 L NO20091081 L NO 20091081L NO 20091081 A NO20091081 A NO 20091081A NO 20091081 A NO20091081 A NO 20091081A NO 20091081 L NO20091081 L NO 20091081L
Authority
NO
Norway
Prior art keywords
organic compounds
epothilone
crystal forms
new crystal
compounds
Prior art date
Application number
NO20091081A
Other languages
English (en)
Norwegian (no)
Inventor
Ernst Kuesters
Michael Mutz
Frank Stowasser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37685905&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20091081(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20091081L publication Critical patent/NO20091081L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20091081A 2006-08-16 2009-03-11 Oganiske forbindelser NO20091081L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119043 2006-08-16
PCT/EP2007/007173 WO2008019820A2 (fr) 2006-08-16 2007-08-14 Composés organiques

Publications (1)

Publication Number Publication Date
NO20091081L true NO20091081L (no) 2009-03-16

Family

ID=37685905

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091081A NO20091081L (no) 2006-08-16 2009-03-11 Oganiske forbindelser

Country Status (22)

Country Link
US (1) US8178566B2 (fr)
EP (1) EP2064216A2 (fr)
JP (1) JP2010500387A (fr)
KR (1) KR20090038902A (fr)
CN (1) CN101506217B (fr)
AR (1) AR062375A1 (fr)
AU (1) AU2007286454A1 (fr)
BR (1) BRPI0715963A2 (fr)
CA (1) CA2658475A1 (fr)
CL (1) CL2007002362A1 (fr)
IL (1) IL196558A0 (fr)
MA (1) MA30656B1 (fr)
MX (1) MX2009001635A (fr)
MY (1) MY148355A (fr)
NO (1) NO20091081L (fr)
NZ (1) NZ574194A (fr)
PE (1) PE20081317A1 (fr)
RU (1) RU2009109352A (fr)
TN (1) TN2009000044A1 (fr)
TW (1) TW200815455A (fr)
WO (1) WO2008019820A2 (fr)
ZA (1) ZA200900227B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2571525A4 (fr) 2010-05-18 2016-04-27 Cerulean Pharma Inc Compositions et procédés de traitement de maladies auto-immunes et autres
CN103910742B (zh) * 2013-01-07 2016-07-13 浙江海正药业股份有限公司 一种制备埃博霉素b无定形粉末的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125921A (en) 1998-02-05 2006-08-30 Novartis Ag Compositions containing organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
UA75365C2 (en) * 2000-08-16 2006-04-17 Bristol Myers Squibb Co Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon
GB0029895D0 (en) 2000-12-07 2001-01-24 Novartis Ag Organic compounds
KR101406635B1 (ko) * 2002-09-23 2014-06-11 브리스톨-마이어스 스큅 컴퍼니 에포틸론 b의 제조, 분리 및 정제 방법, 및 에포틸론 b의 x-선 결정 구조

Also Published As

Publication number Publication date
EP2064216A2 (fr) 2009-06-03
MY148355A (en) 2013-03-29
MX2009001635A (es) 2009-02-23
BRPI0715963A2 (pt) 2013-08-06
AU2007286454A1 (en) 2008-02-21
AR062375A1 (es) 2008-11-05
US8178566B2 (en) 2012-05-15
IL196558A0 (en) 2009-11-18
JP2010500387A (ja) 2010-01-07
WO2008019820A3 (fr) 2008-04-17
WO2008019820A2 (fr) 2008-02-21
TW200815455A (en) 2008-04-01
CN101506217A (zh) 2009-08-12
KR20090038902A (ko) 2009-04-21
RU2009109352A (ru) 2010-09-27
CL2007002362A1 (es) 2008-08-08
PE20081317A1 (es) 2008-10-28
MA30656B1 (fr) 2009-08-03
CN101506217B (zh) 2012-09-05
US20100160393A1 (en) 2010-06-24
NZ574194A (en) 2011-12-22
TN2009000044A1 (en) 2010-08-19
CA2658475A1 (fr) 2008-02-21
ZA200900227B (en) 2009-12-30

Similar Documents

Publication Publication Date Title
CY2020025I1 (el) Αναστολεις βητα-λακταμασων
DK2086960T3 (da) Nye inhibitorer af glutaminylcyclase.
MA32938B1 (fr) Composes organiques
UY30639A1 (es) Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
BRPI0923121A2 (pt) Formas salinas de compostos orgânico
BRPI0718509A2 (pt) compostos orgânicos heterocíclicos
MA32939B1 (fr) Composes organiques
NO20084803L (no) organiske forbindelser
BRPI0718874A2 (pt) Compostos orgânicos
BRPI0718478A2 (pt) Compostos orgânicos
FI20065757A0 (fi) Beta-laktamaasin käyttö
EA201100037A1 (ru) Органические соединения
BRPI0817434A2 (pt) Composto orgânicos
DK2091945T3 (da) Nye inhibitorer af glutaminylcyclase
BRPI0811562A2 (pt) Compostos orgânicos
DOP2013000123A (es) Compuesto heterocíclico y su uso.
FI20070063A0 (fi) Orgaaninen kenttävaikutustransistori
ATE510832T1 (de) Heterocyclische verbindungen als c-fms- kinasehemmer
EA200900945A1 (ru) Новый способ синтеза агомелатина
DK2074123T3 (da) Nye anxiolytiske forbindelser
BRPI0712902A2 (pt) compostos orgânicos
EA200900946A1 (ru) Новый способ синтеза агомелатина
CR10409A (es) Spirocyclic nitriles as protease inhibitors
ATE499367T1 (de) 1,3-dihydroimidazol-2-thionderivate als inhibitoren von dopamin-beta-hydroxylase
BRPI0814772A2 (pt) Indazóis substituídos por 5-piridinona

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application